Company profile

Lamab Biologics company profile

Lamab Biologics operates as a biotechnology company. Lamab Biologics develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases.

Business identity

Operating status
Active
Company type
For Profit
Founded
2023-01-01

Headquarters

Headquarters
Uxbridge, Ontario, Canada
Country code
CA
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$25M
Last funding
Series Unknown / $25M / 2023-02-08
Last equity funding
Series Unknown / $25M
Investors
1
Lead investors
1

Founders and investors

Lead investors

TVM Capital

Investors

TVM Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.